These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3527251)

  • 1. Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis.
    Heagerty AH; Kennedy AR; Leigh IM; Purkis P; Eady RA
    Br J Dermatol; 1986 Aug; 115(2):125-31. PubMed ID: 3527251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 19-DEJ-1, a hemidesmosome-anchoring filament complex-associated monoclonal antibody. Definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa.
    Fine JD; Horiguchi Y; Couchman JR
    Arch Dermatol; 1989 Apr; 125(4):520-3. PubMed ID: 2649012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal binding of an anti-amnion antibody to epidermal basement membrane provides a novel diagnostic probe for junctional epidermolysis bullosa.
    Kennedy AR; Heagerty AH; Ortonne JP; Hsi BL; Yeh CJ; Eady RA
    Br J Dermatol; 1985 Dec; 113(6):651-9. PubMed ID: 3913455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KF-1 monoclonal antibody defines a specific basement membrane antigen defect in dystrophic forms of epidermolysis bullosa.
    Fine JD; Breathnach SM; Hintner H; Katz SI
    J Invest Dermatol; 1984 Jan; 82(1):35-8. PubMed ID: 6361168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis of dominant and recessive dystrophic epidermolysis bullosa: application and limitations in the use of KF-1 and LH 7:2 monoclonal antibodies and immunofluorescence mapping technique.
    Fine JD; Eady RA; Levy ML; Hejtmancik JF; Courtney KB; Carpenter RJ; Holbrook KA; Hawkins HK
    J Invest Dermatol; 1988 Nov; 91(5):465-71. PubMed ID: 3049834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroitin 6-sulfate proteoglycan but not heparan sulfate proteoglycan is abnormally expressed in skin basement membrane from patients with dominant and recessive dystrophic epidermolysis bullosa.
    Fine JD; Couchman JR
    J Invest Dermatol; 1989 Apr; 92(4):611-6. PubMed ID: 2522973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a functional defect of the lamina lucida in recessive dystrophic epidermolysis bullosa demonstrated by suction blisters.
    Tidman MJ; Eady RA
    Br J Dermatol; 1984 Oct; 111(4):379-87. PubMed ID: 6487542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistological localization of three basement membrane components in various forms of epidermolysis bullosa.
    Kero M; Peltonen L; Foidart JM; Savolainen ER
    J Cutan Pathol; 1982 Oct; 9(5):316-28. PubMed ID: 7142519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDA-1 monoclonal antibody. An excellent reagent for immunofluorescence mapping studies in patients with epidermolysis bullosa.
    Fine JD; Gay S
    Arch Dermatol; 1986 Jan; 122(1):48-51. PubMed ID: 3510588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the epidermolysis bullosa acquisita antigen by LH 7.2 monoclonal antibody: use in diagnosis.
    Tatnall FM; Whitehead PC; Black MM; Wojnarowska F; Leigh IM
    Br J Dermatol; 1989 Apr; 120(4):533-9. PubMed ID: 2730844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
    Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
    Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using immunofluorescence (antigen) mapping in the diagnosis and classification of epidermolysis bullosa: a first report from Iran.
    Barzegar M; Asadi-Kani Z; Mozafari N; Vahidnezhad H; Kariminejad A; Toossi P
    Int J Dermatol; 2015 Oct; 54(10):e416-23. PubMed ID: 26220012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
    Feinstein JA; Jambal P; Peoples K; Lucky AW; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Hook KP; Levin LE; Morel KD; Paller AS; McCuaig CC; Powell J; Eichenfield LF; Price H; Levy ML; Schachner LA; Browning JC; Bayliss S; Jahnke M; Shwayder T; Glick SA; Bruckner AL
    JAMA Dermatol; 2019 Feb; 155(2):196-203. PubMed ID: 30586139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular expression of type VII collagen during wound healing in severe recessive dystrophic epidermolysis bullosa and normal human skin.
    McGrath JA; Leigh IM; Eady RA
    Br J Dermatol; 1992 Oct; 127(4):312-7. PubMed ID: 1419750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraepidermal type VII collagen. Evidence for abnormal intracytoplasmic processing of a major basement membrane protein in rare patients with dominant and possibly localized recessive forms of dystrophic epidermolysis bullosa.
    Fine JD; Horiguchi Y; Stein DH; Esterly NB; Leigh IM
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):188-95. PubMed ID: 2104504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunofluorescence mapping for diagnosis of congenital epidermolysis bullosa].
    Cepeda-Valdés R; Pohla-Gubo G; Borbolla-Escoboza JR; Barboza-Quintana O; Ancer-Rodríguez J; Hintner H; Salas-Alanis JC
    Actas Dermosifiliogr; 2010 Oct; 101(8):673-82. PubMed ID: 20965010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GB3 monoclonal antibody for the diagnosis of junctional epidermolysis bullosa: results of a multicenter study.
    Schofield OM; Fine JD; Verrando P; Heagerty AH; Ortonne JP; Eady RA
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1078-83. PubMed ID: 2273105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recessive dystrophic epidermolysis bullosa phenotype is preserved in xenografts using SCID mice: development of an experimental in vivo model.
    Kim YH; Woodley DT; Wynn KC; Giomi W; Bauer EA
    J Invest Dermatol; 1992 Feb; 98(2):191-7. PubMed ID: 1370678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructure and molecular pathogenesis of epidermolysis bullosa.
    Shinkuma S; McMillan JR; Shimizu H
    Clin Dermatol; 2011; 29(4):412-9. PubMed ID: 21679868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type VII collagen is a normal component of epidermal basement membrane, which shows altered expression in recessive dystrophic epidermolysis bullosa.
    Leigh IM; Eady RA; Heagerty AH; Purkis PE; Whitehead PA; Burgeson RE
    J Invest Dermatol; 1988 May; 90(5):639-42. PubMed ID: 3283248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.